Arecor Therapeutics plc (FRA:6UI)

Arecor Therapeutics Statistics

Total Valuation

FRA:6UI has a market cap or net worth of EUR 31.14 million. The enterprise value is 29.19 million.

Market Cap	31.14M
Enterprise Value	29.19M

Important Dates

The next estimated earnings date is Wednesday, December 24, 2025.

Earnings Date	Dec 24, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	37.76M
Shares Outstanding	n/a
Shares Change (YoY)	+20.83%
Shares Change (QoQ)	+4.15%
Owned by Insiders (%)	15.96%
Owned by Institutions (%)	47.99%
Float	21.27M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.27
PB Ratio	9.35
P/TBV Ratio	9.43
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-3.09
EV / Sales	5.07
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.02

Financial Position

The company has a current ratio of 2.05, with a Debt / Equity ratio of 0.06.

Current Ratio	2.05
Quick Ratio	2.00
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	-0.03
Interest Coverage	-308.05

Financial Efficiency

Return on equity (ROE) is -204.29% and return on invested capital (ROIC) is -82.64%.

Return on Equity (ROE)	-204.29%
Return on Assets (ROA)	-44.39%
Return on Invested Capital (ROIC)	-82.64%
Return on Capital Employed (ROCE)	-189.64%
Revenue Per Employee	134,185
Profits Per Employee	-214,866
Employee Count	44
Asset Turnover	0.65
Inventory Turnover	12.39

Taxes

Income Tax	-309,149
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -19.21% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-19.21%
50-Day Moving Average	0.60
200-Day Moving Average	0.72
Relative Strength Index (RSI)	66.61
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:6UI had revenue of EUR 5.90 million and -9.45 million in losses. Loss per share was -0.26.

Revenue	5.90M
Gross Profit	1.87M
Operating Income	-6.47M
Pretax Income	-9.76M
Net Income	-9.45M
EBITDA	-6.24M
EBIT	-6.47M
Loss Per Share	-0.26

Balance Sheet

The company has 2.20 million in cash and 201,821 in debt, giving a net cash position of 2.00 million.

Cash & Cash Equivalents	2.20M
Total Debt	201,821
Net Cash	2.00M
Net Cash Per Share	n/a
Equity (Book Value)	3.33M
Book Value Per Share	0.09
Working Capital	2.85M

Cash Flow

In the last 12 months, operating cash flow was -7.14 million and capital expenditures -123,659, giving a free cash flow of -7.26 million.

Operating Cash Flow	-7.14M
Capital Expenditures	-123,659
Free Cash Flow	-7.26M
FCF Per Share	n/a

Margins

Gross margin is 31.67%, with operating and profit margins of -109.56% and -160.13%.

Gross Margin	31.67%
Operating Margin	-109.56%
Pretax Margin	-165.36%
Profit Margin	-160.13%
EBITDA Margin	-105.65%
EBIT Margin	-109.56%
FCF Margin	n/a

Dividends & Yields

FRA:6UI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.83%
Shareholder Yield	-20.83%
Earnings Yield	-30.36%
FCF Yield	-23.31%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:6UI has an Altman Z-Score of -8.54 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-8.54
Piotroski F-Score	3